Abstract
The new infectious disease caused by SARS-CoV-2 virus has remarkably modified the current regulatory frameworks in different areas of the public health system. Among them, historical diseases that had previously been controlled were once again unleashed, especially in developing countries where regulation policies are still controversial. For instance, the management of tuberculosis infection has been widely affected by the SARS-CoV-2 infection in terms of prevention, diagnosis, treatment, and proper follow-up. The SARS-CoV-2 infection has negatively altered local epidemiological surveillance; therefore, a new management and regulatory framework regarding the current circumstances must be developed to improve the control of local diseases. The present article offers an overview of the regional guidelines regarding tuberculosis management and the impact of the novel SARS-CoV-2 infection on their implementation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Latin american journal of clinical sciences and medical technology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
